Stanford University
Showing 391-400 of 1,198 Results
-
Ilang M. Guiroy, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Ilang M. Guiroy is a board-certified, fellowship-trained physician scientist and psychiatrist at Stanford Health Care and Lucile Packard Children’s Hospital Stanford. She is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Guiroy is director of the Guiroy Lab at Stanford. Her research explores maternal-infant mental health and digital mental health, including the use of social media, digital communities, and AI for mental health. She developed a groundbreaking telehealth platform to deliver psychotherapy via group chat to digital communities.
Dr. Guiroy treats mental health conditions in patients throughout the lifespan, from conception to elder age. She has a special interest in infant, child, and maternal mental health and provides medication management during pregnancy, postpartum, and breastfeeding. Dr. Guiroy provides expert support to patients coping with birth trauma, transitioning to motherhood, and fostering infant attachment and maternal bonding. Dr. Guiroy is skilled in over twelve therapy modalities including maternal-infant dyadic therapy, interpersonal therapy (IPT), and cognitive behavioral therapy (CBT).
Dr. Guiroy has published her research in peer-reviewed journals, including Journal of Technology in Behavioral Science and Telemedicine and e-Health. She has also presented to her peers at national conferences for the American Academy of Child and Adolescent Psychiatry (AACAP) and the Society for Digital Mental Health (SDMH).
Dr. Guiroy is a member of the AACAP, the SDMH, the American Psychiatric Association (APA), and the International Marcé Society for Perinatal Mental Health. -
Kritee Gujral
Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
Current Role at Stanford- Instructor (Affiliated), Stanford Department of Psychiatry and Behavioral Sciences
- Research Scientist, Stanford Center for Responsible and Effective AI Technology Enhancement (CREATE)
- Researcher & Data Analyst, Stanford-Surgery Policy Improvement Research & Education Center (S-SPIRE) -
Matthew Gunther, MD, MA
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Assistant Professor (By courtesy), Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsDr. Gunther’s scholarly work focuses on neuropsychiatric syndromes arising in the context of medical illness, with particular emphasis on delirium, catatonia, psychopharmacology in the medically ill, and the psychiatric sequelae of critical illness. His research spans the identification, assessment, and management of acute brain dysfunction in hospitalized and critically ill populations, including studies evaluating delirium prediction tools, bedside diagnostic instruments, and neurorecovery outcomes following medical insults. He has contributed to the validation and clinical application of the Stanford Proxy Test for Delirium (S-PTD) and related delirium risk stratification efforts, and has authored systematic reviews and case-based scholarship addressing catatonia, alcohol withdrawal syndromes, and medication-related neurotoxicity. In parallel, Dr. Gunther’s work in integrated behavioral health and medical education examines how psychiatry-led, skills-based interventions can improve recognition of neuropsychiatric and trauma-related symptoms in primary care and inpatient medical settings. Across these domains, his research emphasizes translational, clinically grounded approaches that equip non-psychiatric clinicians to manage complex neuropsychiatric presentations with greater confidence and precision.
-
Laura Michele Hack
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Laura M. Hack is an Assistant of Psychiatry and Behavioral Sciences at Stanford University and the Veterans Affairs Palo Alto Health Care System (PAVAHCS). As Associate Director of the Novel & Precision Neurotherapeutics Program at the Stanford Center for Precision Mental Health, Dr. Hack leads a translational, patient-centered research group that designs and implements mechanistic clinical trials for biologically informed subtypes of Mood, Anxiety, and Trauma-related Disorders (MATRDs).
Her work spans repurposed pharmacologic interventions (e.g., guanfacine), neuromodulation techniques (e.g., repetitive transcranial magnetic stimulation [TMS]), and therapies involving altered states of consciousness (i.e., ketamine, MDMA, psilocybin, and anesthesia-induced dreaming). Across these modalities, Dr. Hack's focus is on tailoring treatment based on objective, biologically anchored markers that match the patient’s profile.
Dr. Hack also directs the Stanford Precision Psychiatry Clinic, a high-touch, high-tech consultation service designed to support individuals with a primary diagnosis of major depression and often comorbid MATRDs. This clinic integrates the investigational use of high-definition neuroimaging (personalized brain circuit scores) with symptom profiling, neurocognitive testing, pharmacogenomic analysis, inflammatory biomarkers, and standard blood work. The aim is to generate individualized insights that inform treatment decisions and help patients better understand the biological underpinnings of their condition—often reducing self-blame and empowering engagement in care.
In her role as Deputy Director as well as Ketamine and Education Lead of the Precision Neuromodulation Clinic (PNC) at PAVAHCS, Dr. Hack specializes in delivering evidence-based, FDA-cleared interventions including TMS and intranasal ketamine for Veterans experiencing treatment-resistant depression, frequently in the context of comorbid PTSD.
